Jun Zhang

Dr. Jun Zhang


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 October 2023 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
YCYatao Chen
Yatao Chen
YWYuzhi Wang
Yuzhi Wang
TWTan Wang
Tan Wang
XPXiaoying Pei
Xiaoying Pei
JZJun Zhang
Jun Zhang
YLYan Liu
Yan Liu

27 September 2024 in Journal of Biological Chemistry
Verified
Journal Article
Open access
XPXiaoying Pei
Xiaoying Pei
YCYatao Chen
Yatao Chen
LLLinjing Liu
Linjing Liu
LMLi Meng
Li Meng
JZJun Zhang
Jun Zhang
LCLiming Chen
Liming Chen
MYC is one of the most extensively studied oncogenic proteins and is closely associated with the occurrence and progression of many tumors. Previous studies have shown that MYC regulates cell fate through its liquid-liquid phase separation mechanism, which is dependent on two disordered domains within its N-terminal transcriptional activation regions. In this study, we revealed that the negatively charged conserved region (E242-E261) of the MYC protein controls its condensation formation and irreversible aggregation through multivalent electrostatic interactions. Furthermore, deletion or mutation of the E242-E261 amino acids in the MYC protein enhances the transcriptional function of MYC by altering its aggregation capacity and subsequently promoting cancer cell proliferation. The discovery of the negatively charged region and its regulatory action on the phase separation of MYC provides a new understanding of the aggregation and function of MYC.

25 November 2024 in Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
Verified
Journal Article
Closed access
LCLong Chen
Long Chen
MZMenglu Zhao
Menglu Zhao
LLLinjing Liu
Linjing Liu
TWTan Wang
Tan Wang
XGXue Gong
Xue Gong
JZJun Zhang
Jun Zhang

3 April 2023
Verified
Other
Open access
TCTian-Yu Cai
Tian-Yu Cai
XLXiao-Wen Liu
Xiao-Wen Liu
HZHong Zhu
Hong Zhu
JCJi Cao
Ji Cao
JZJun Zhang
Jun Zhang
BYBo Yang
Bo Yang
PDF file - 135K, Supplementary Table S1. CI Values of SN-38 at Concentrations Applied in Combination with Tirapazamine in Different Liver Cell Lines; Supplementary Table S2. In Vivo Efficacy of CPT-11 in Combination with Tirapazamine; and supplementary figure legends.

3 April 2023
Verified
Other
Open access
TCTian-Yu Cai
Tian-Yu Cai
XLXiao-Wen Liu
Xiao-Wen Liu
HZHong Zhu
Hong Zhu
JCJi Cao
Ji Cao
JZJun Zhang
Jun Zhang
BYBo Yang
Bo Yang
PDF file - 89K, Figure S6. Overexpression of HIF-1α could weaken the synergistic effect of SN-38 and TPZ.

3 April 2023
Verified
Other
Open access
TCTian-Yu Cai
Tian-Yu Cai
XLXiao-Wen Liu
Xiao-Wen Liu
HZHong Zhu
Hong Zhu
JCJi Cao
Ji Cao
JZJun Zhang
Jun Zhang
BYBo Yang
Bo Yang
PDF file - 159K, Figure S1. Depletion of HIF-1alpha could reverse hypoxia-induced resistance to topoisomerase I inhibitors.